Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Suven Life Sciences

BSE: 530239|NSE: SUVEN|ISIN: INE495B01038|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 18, 16:00
280.50
15.05 (5.67%)
VOLUME 58,172
LIVE
NSE
Oct 18, 15:59
280.55
15.75 (5.95%)
VOLUME 366,274
Announcements on Suven Life Sci

16th-Oct-2019 16:21Source: NSE

Suven Life Sciences Limited

Suven Life Sciences Limited has informed the Exchange regarding Credit Rating

16th-Oct-2019 16:01Source: BSE

Suven Life Sciences- Announcement under Regulation 30 (LODR)-Credit Rating

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to intimate you that the CRISIL has assigned the following ratings to the Bank facilitie...

11th-Oct-2019 12:47Source: BSE

Suven Life Sciences- Shareholding for the Period Ended September 30, 2019

Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here

30th-Sep-2019 14:06Source: BSE

Suven Life Sciences- Closure of Trading Window

We wish to inform you that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives and covered under the said Code of the...

24th-Sep-2019 14:52Source: NSE

Suven Life Sciences Limited

Suven Life Sciences Limited has informed the Exchange regarding a press release dated September 24, 2019, titled "First Patient randomized in a Phase 2A, Proof of Concept (PoC) clinical trial of SUVN-...

24th-Sep-2019 14:42Source: BSE

Suven Life Sciences- Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find enclosed Press Release of our company titled 'First Patient randomized in a Phase 2A, Proof of Concept (PoC) clinical trial of SUVN-G3031 for the treatment of Narcolepsy associated with or...

21st-Sep-2019 18:56Source: BSE

Suven Life Sciences- Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Suven Life Sciences Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

21st-Sep-2019 18:39Source: BSE

Suven Life Sciences- Combined Voting Results Of The Business Transacted At The Hon''ble National Company Law Tribunal ("NCLT') Convened Meetings Of The Equity Shareholders, Secured Creditors And Unsecured Creditors Of The Company Held On September 2

Please find enclosed Combined Voting Results of the Business transacted at the Hon''''ble National Company Law Tribunal ("NCLT'') convened Meetings of the Equity Shareholders, Secured Creditors and Un...

19th-Aug-2019 14:41Source: NSE

Suven Life Sciences Limited

Suven Life Sciences Limited has informed the Exchange regarding ''Newspaper advertisements pertaining to Notice of the National Company Law Tribunal Convened Meeting of Equity Shareholders, Secured an...

1 2 3 4 5 Next >>
Quick Links for Suven Life Sciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.